The Hippo transducer TAZ as a biomarker of pathological complete response in HER2-positive breast cancer patients treated with trastuzumab-based neoadjuvant therapy
暂无分享，去创建一个
R. Maria | M. Mottolese | A. Pagliuca | M. Bartucci | I. Terrenato | F. Sperati | P. Vici | L. Pizzuti | D. Sergi | M. Barba | M. Maugeri-Saccà | T. Gamucci | D. Angelucci | C. Natoli | L. Lauro | A. Benedetto | M. Ramieri | Rosanna Dattilo